A pyrimidine base
Related Products
Parent Compound(s)
29448Brivudine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(E)-5-(2-Bromovinyl)uracil

Item No. 21030

Technical Information
Formal Name
5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
CAS Number
69304-49-0
Synonyms
  • BVU
Molecular Formula
C6H5BrN2O2
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 60 mg/mLDMSO: 53 mg/mLEthanol: 0.8 mg/mLPBS (pH 7.2): 8 mg/mL
λmax
250, 290 nm
SMILES
O=C1NC(NC=C1/C=C/Br)=O
InChi Code
InChI=1S/C6H5BrN2O2/c7-2-1-4-3-8-6(11)9-5(4)10/h1-3H,(H2,8,9,10,11)/b2-1+
InChi Key
BLXGZIDBSXVMLU-OWOJBTEDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    (E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo.1,2,3 BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner.1,4 It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil (5-FU; Item No. 14416) in a P388 murine leukemia model when administered at a dose of 200 µmol/kg, increasing survival time.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ogura, K., Nishiyama, T., Takubo, H., et alSuicidal inactivation of human dihydropyrimidine dehydrogenase by (E)-5-(2-bromovinyl)uracil derived from the antiviral, sorivudine. Cancer Lett. 122(1-2), 107-113 (1998).

    2. Desgranges, C., Razaka, G., Drouiller, F., et alRegeneration of the antiviral drug (E)-5-(2-bromovinyl)-2′-deoxyuridine in vivo. Nucleic Acids Res. 12(4), 2081-2110 (1984).

    3. De Clercq, E., Desgranges, C., Herdewijn, P., et alSynthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J. Med. Chem. 29(2), 213-217 (1986).

    4. Desgranges, C., Razaka, G., De Clercq, E., et alEffect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice. Cancer Res. 46(3), 1094-1101 (1986).